Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q1 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.43), in-line with the analyst estimate of ($0.43).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Berkshire adds significantly to Alphabet position, starts small position in DR Horton